Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-20-055172

EVP, Finance sold 375 shares at $87.99 ($32,996)

From the SEC's structured data for this filing

Trades in this filing

Sharp Shalini · EVP, Finance

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-14 Sale : show line 1 in the form −375 $87.99 $32,996 97,812 D
Open-market sales · 375 sh · avg $87.99 · $32,996
Loading xslF345X03/doc4.xml…